SynthesisBMC public health2025
Psychotropic medication non-adherence and its determinants among people living with mental illnesses in Ethiopia: systematic review and meta-analysis study.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Psychotropic medication non-adherence and its determinants among adult psychiatric patients in Ethiopia.Social psychiatry and psychiatric epidemiology · 2026Article
- Medication Adherence, Treatment Attitudes, and Beliefs About Medicines in Romanian Psychiatric Patients: A Cross-Sectional Study.Diseases (Basel, Switzerland) · 2026Article
- Prevalence and determinants of antidepressant non-adherence among patients with major depressive disorder in Ethiopia: a multi-center cross sectional study.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver half of patients take medications incorrectly, with non-adherence being a significant challenge in managing mental illnesses and to healthcare systems globally. In mental health, non-adherence to psychotropic medications exacerbates symptoms, increases relapse rates, and contributes to treatment resistance, higher hospitalization rates, and mortality. It also places a financial burden on healthcare systems through preventable hospitalizations and prolonged treatments. Understanding the prevalence and determinants of non-adherence is particularly critical in low-resource settings like Ethiopia, where mental health services are underfunded and sociocultural factors influence treatment behaviors. Therefore, this study aimed to estimate the pooled prevalence and determinants of psychotropic medication non-adherence in Ethiopia.
methodsPrimary articles were sourced from PubMed (Medline), EMBASE, CINAHL, Web of Science, PsycINFO, Google, and Google Scholar. The review included studies reporting the prevalence and determinants of psychotropic medication non-adherence among individuals with mental illness. Data were extracted using Microsoft Excel and analyzed in STATA 14. A random effects model was applied to estimate the pooled prevalence, and subgroup analyses were performed to explore heterogeneity. Publication bias was assessed using Egger's test and a funnel plot.
resultsSeventeen studies with 7,097 participants were included. The pooled prevalence of psychotropic medication non-adherence was 43.98% (38.15, 49.81). Subgroup analysis revealed regional variations with prevalence rates of 52.85% in Harari, 52.4% in Amhara, 46.39% in Oromia, 39.8% in Addis Ababa, and 27.42% in Tigray. Significant determinants included negative attitudes toward treatment (OR: 3.69; 95% CI: 2.73-4.99), lack of insight (OR: 3.20; 95% CI: 1.71-5.99), medication side effects (OR: 2.84; 95% CI: 2.05-3.93), perceived stigma (OR: 2.41; 95% CI: 1.87-3.10), substance use (OR: 2.36; 95% CI: 2.02-2.74), and poor social support (OR: 2.30; 95% CI: 1.61-3.29). CONCLUSIONS AND RECOMMENDATIONS: This study found that over four in ten people with mental illness were non-adherent to medications. It is recommended to design intervention strategies that address the factors associated with non-adherence to psychotropic medication. PROSPERO REGISTRATION: CRD42024563343.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.